EyePromise Introduces Heyedrate™ Clinical: A Next Generation Artificial Tear

Clinically Validated, Time-Tested Artificial Tear Designed to Address Temporary Relief of Dry Eye BLUE BELL, Pa., May 18, 2026 /PRNewswire/ -- EyePromise, the maker of the #1 doctor-recommended nutraceutical for occasional dry eye in the U.S., today announces the launch of Heyedrate...